ABCL — AbCellera Biologics Inc. stock price, charts and financials

QT62AbCellera Biologics Inc.

AbCellera Biologics Inc. (NASDAQ: ABCL) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
12.63
-0.10-0.79%
OverviewShort InterestFilings
ABCLQT62AbCellera Biologics Inc.·NASDAQ
12.63-0.79%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 24, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20264Statement of changes in beneficial ownership
Aug 13, 20268-KCurrent report
Aug 13, 2026424B5Prospectus
Aug 13, 20264Statement of changes in beneficial ownership
Aug 11, 2026424B5Prospectus
Aug 10, 20268-KCurrent report
Aug 07, 20268-KCurrent report
Aug 05, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jul 29, 20268-KCurrent report
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20263Initial statement of beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20268-KCurrent report
Jun 17, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 11, 20263Initial statement of beneficial ownership
Jun 05, 20268-KCurrent report
May 18, 20264Statement of changes in beneficial ownership
#1 / 25 of 244
Page
▼
/ 10